Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA‐REG OUTCOME trial

AIM: To investigate the association of the Thrombolysis In Myocardial Infarction (TIMI) Risk Score for Heart Failure in Diabetes (TRS‐HF(DM)) with mortality using data from the EMPA‐REG OUTCOME trial. MATERIALS AND METHODS: In EMPA‐REG OUTCOME, patients with type 2 diabetes and atherosclerotic cardi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Verma, Subodh, Sharma, Abhinav, Zinman, Bernard, Ofstad, Anne Pernille, Fitchett, David, Brueckmann, Martina, Wanner, Christoph, Zwiener, Isabella, George, Jyothis T., Inzucchi, Silvio E., Butler, Javed, Mazer, C. David
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318207/
https://ncbi.nlm.nih.gov/pubmed/32227432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados